F Berglund - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F Berglund

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

The Journal of Clinical Endocrinology and Metabolism|August 1, 2019

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice GuidelineJames L Rosenzweig, George L Bakris, Lars F Berglund, et al.

Medrxiv : the Preprint Server for Health Sciences|January 10, 2024

Impaired incretin homeostasis in non-diabetic moderate-severe CKDArmin Ahmadi, Jorge Gamboa, Jennifer E Norman, et al.

Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2024

Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKDArmin Ahmadi, Jorge Gamboa, Jennifer E Norman, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

The Journal of Clinical Endocrinology and Metabolism|August 1, 2019

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice GuidelineJames L Rosenzweig, George L Bakris, Lars F Berglund, et al.

Medrxiv : the Preprint Server for Health Sciences|January 10, 2024

Impaired incretin homeostasis in non-diabetic moderate-severe CKDArmin Ahmadi, Jorge Gamboa, Jennifer E Norman, et al.

Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2024

Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKDArmin Ahmadi, Jorge Gamboa, Jennifer E Norman, et al.

Pageof 5